Covidien Launches New Shiley™ Neonatal and Pediatric Tracheostomy Tubes

  Covidien Launches New Shiley™ Neonatal and Pediatric Tracheostomy Tubes

 Cuffless portfolio enhances tracheostomy care and safety for young patients

Business Wire

BOULDER, Colo. -- April 15, 2013

Covidien (NYSE: COV), a leading global provider of healthcare products and
recognized innovator in patient monitoring and respiratory care devices, today
added a new product to its family of Shiley^TM neonatal and pediatric
tracheostomy tubes. The new cuffless product will help enhance patient care
and safety within the hospital and home care environments.

“This new product portfolio represents an important step forward in the care
of young patients dependent on tracheostomy tubes,” said Robert J. White,
President, Respiratory and Monitoring Solutions, Covidien. “For more than 40
years, clinicians and patients have trusted the Shiley brand for their
tracheostomy needs. We are pleased to offer an expanded range of
industry-leading solutions for meeting their needs across hospital and home
care environments.”

Shiley portfolio innovations for the cuffless design include:

  *An expanded range of tube sizes down to a 2.5mm inner diameter to
    accommodate the smallest patients – an option that hasn’t previously
    existed in the Shiley portfolio.
  *A soft, clear flange that facilitates easier examination of the underlying
    skin for infection and eases trach-tube holder insertion.
  *Tubes manufactured with a medical grade PVC, with a citric-based,
    non-phthalate plasticizer and meet the latest patient safety standards.

The Shiley neonatal and pediatric tracheostomy tubes were recently approved
for sale in the United States, Canada and Europe. More information on the
product portfolio is available by visiting Covidien also
offers tracheostomy support resources for patients and physicians through its
recently enhanced website


Covidien is a leading global healthcare products company that creates
innovative medical solutions for better patient outcomes and delivers value
through clinical leadership and excellence. Covidien manufactures, distributes
and services a diverse range of industry-leading product lines in three
segments: Medical Devices, Pharmaceuticals and Medical Supplies. With 2012
revenue of $11.9 billion, Covidien has 43,000 employees worldwide in 70
countries, and its products are sold in over 140 countries.

Please visit to learn more about our business.


Rhonda Luniak, 303-305-2263
Vice President
R&MS Communications
Bruce Farmer, 508-452-4372
Vice President
Public Relations
Coleman Lannum, CFA, 508-452-4343
Vice President
Investor Relations
Todd Carpenter, 508-452-4363
Senior Director
Investor Relations
Press spacebar to pause and continue. Press esc to stop.